Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration With NVIDIA
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration With NVIDIA
"We are thrilled to collaborate with NVIDIA to make single-molecule proteomics more accessible to researchers," said John Vieceli, Ph.D., Chief Product Officer of Quantum-Si. We have been leveraging AI protein structure prediction tools with NVIDIA BioNeMo, both in the cloud and on-premises to design new and improved biomolecules. Now, we are excited to apply NVIDIA technology for downstream data processing and interpretation applications for Proteus.Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing and Accelerated Data Processing
合作將推動下一代蛋白質測序和加速數據處理的人工智能驅動進展
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus, and advance Quantum-Si's core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing.
康涅狄格州布蘭福德--(業務電訊)--量子硅公司（納斯達克：QSI）（"量子硅"，"QSI"或"公司"），一家蛋白質測序公司，今天宣佈與英偉達合作開發其新的蛋白質組學平台Proteus，並利用英偉達的人工智能和加速計算推動量子硅的核心技術，包括氨基酸結合劑和氨肽酶。
This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leveraging NVIDIA accelerated computing and Quantum-Si's advanced single-molecule protein sequencing and detection technologies, the collaboration aims to develop a robust data processing system. This system will keep pace with Quantum-Si's rapidly evolving technology advancements, generating single-molecule protein insights to deepen our understanding of the proteome and develop innovative solutions through research, drug discovery, and healthcare AI.
此次合作旨在顯著提升數據處理速度以處理Proteus帶來的增加數據量。通過利用NVIDIA的加速計算和Quantum-Si的先進單分子蛋白質測序和檢測技術，合作將致力於開發強大的數據處理系統。該系統將跟上Quantum-Si快速發展的技術進展，產生單分子蛋白質的見解，深化我們對蛋白質組的理解，並通過研究、藥物發現和醫療保健人工智能開發創新解決方案。
"We are thrilled to collaborate with NVIDIA to make single-molecule proteomics more accessible to researchers," said John Vieceli, Ph.D., Chief Product Officer of Quantum-Si. We have been leveraging AI protein structure prediction tools with NVIDIA BioNeMo, both in the cloud and on-premises to design new and improved biomolecules. Now, we are excited to apply NVIDIA technology for downstream data processing and interpretation applications for Proteus.
"我們很高興與英偉達合作，爲研究人員提供更易獲取的單分子蛋白質組學技術，" Quantum-Si 的首席產品官John Vieceli博士表示。我們一直在利用英偉達BioNeMo的人工智能蛋白質結構預測工具，在雲端和本地設計新的、改進的生物分子。現在，我們很興奮地應用英偉達的技術進行下游數據處理和 Proteus 的解釋應用。
"Sequencing proteins to derive insights requires advanced processing capabilities that can handle vast volumes of data," said George Vacek, Global Head of Genomics Alliances at NVIDIA. "Applying NVIDIA technology for accelerated computing and AI, Quantum-Si's platform for proteomics and multi-omics can make a significant impact on healthcare and life sciences AI and research."
"測序蛋白質以獲得洞見需要能夠處理海量數據的先進處理能力，" NVIDIA全球基因組聯盟負責人George Vacek表示。"應用英偉達技術進行加速計算和人工智能，Quantum-Si的蛋白質組學和多組學平台可以在醫療保健和生命科學AI研究上產生重大影響。"
About Quantum-Si Incorporated
關於Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company, is focused on revolutionizing the growing field of proteomics. The Company's Platinum instrument enables Next-Generation Protein Sequencing that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools.
量子硅公司，蛋白質測序公司，專注於革新快速發展的蛋白質組學領域。公司的鉑金儀器使得下一代蛋白質測序成爲可能，從而推動蛋白質組研究、藥物發現和診斷超越現有蛋白質組工具的能力。
譯文內容由第三人軟體翻譯。
